Health
Are you pursuing MRT as a treatment for infertility? Tell us about your experience
Publication: STAT
Author: STAT Staff
Source published: 02/11/2026, 09:30:00 UTC
Briefing created: 03/11/2026, 06:57:59 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 02/11/2026, 21:06:25 UTC.
Briefings
STAT investigated how mitochondrial replacement techniques (MRT), also known as three-parent IVF, are marketed as fertility treatments for older women. The procedure is illegal in the United States but accessible through a for-profit tourism industry connecting women in the U.S. and Europe to clinics abroad. Evidence indicates scant clinical evidence supports the effectiveness of MRT for this demographic.
Key points
- MRT is marketed as a fertility treatment for older women despite scant clinical evidence of its effectiveness.
- The procedure is illegal in the United States but accessible via a for-profit tourism industry connecting women in the U.S. and Europe to clinics abroad.
Context
STAT investigated the marketing of mitochondrial replacement techniques (MRT) as fertility treatments for older women. The procedure is illegal in the United States but accessible through a for-profit tourism industry connecting women in the U.S. and Europe to clinics abroad.
Limitations
Evidence is limited to a single article from November 2026. No clinical trial data, patient outcomes, or regulatory status beyond illegality in the U.S. are provided.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 03/11/2026, 06:57:59 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeigz2b7fi3l6laf7sfjm376bwwebghrw2kbxxlhd2vrghrny7v4424